Premium
NEW TREATMENT PARADIGM FOR PROSTATE CANCER: ABARELIX INITIATION THERAPY FOR IMMEDIATE TESTOSTERONE SUPPRESSION FOLLOWED BY A LUTEINIZING HORMONE‐RELEASING HORMONE AGONIST
Author(s) -
Tombal Bertrand
Publication year - 2012
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2012.10983.x
Subject(s) - prostate cancer , testosterone (patch) , luteinizing hormone , medicine , agonist , oncology , hormone , gynecology , cancer , receptor